<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2016-22-2-184-191</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-425</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Влияние степени тяжести бронхиальной астмы на ремоделирование сердца у пациентов с артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Effects of asthma severity on cardiac remodeling in patients with arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Одегова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Odegova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-терапевт ГБОУ ВПО «Кировская ГМА» МЗ РФ</p></bio><bio xml:lang="en"><p>MD, Physician, Kirov State Medical Academy</p></bio><email xlink:type="simple">all.odegova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарловская</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarlovskaya</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор кафедры внутренних болезней ГБОУ ВПО «Нижегородская ГМА» МЗ РФ</p></bio><bio xml:lang="en"><p>MD, PhD, DSc, Professor of Cardiology, Department of Internal Medicine, Nizhny Novgorod State Medical Academy</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Государственное бюджетное образовательное учреждение высшего профессионального образования «Кировская государственная медицинская академия» Министерства здравоохранения Российской Федерации, Киров, Россия ГБОУ ВПО «Кировская ГМА» МЗ РФ, ул. К. Маркса, д. 112, г. Киров, Россия, 610027. Тел.: +7(8332)56–03–01, +7(8332)62–77–28,+7(8332)62–77–28<country>Россия</country></aff><aff xml:lang="en">Kirov State Medical Academy, Kirov, Russia  112 K. Marksa street, Kirov, 610027 Russia. Phone: +7(8332)56–03–01, +7(8332)62–77–28, +7(8332)62–77–28<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Государственное бюджетное образовательное учреждение высшего профессионального образования «Нижегородская государственная медицинская академия» Министерства здравоохранения Российской Федерации, Нижний Новгород, Россия<country>Россия</country></aff><aff xml:lang="en">Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>22</day><month>08</month><year>2016</year></pub-date><volume>22</volume><issue>2</issue><fpage>184</fpage><lpage>191</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Одегова А.А., Тарловская Е.И., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Одегова А.А., Тарловская Е.И.</copyright-holder><copyright-holder xml:lang="en">Odegova A.A., Tarlovskaya E.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/425">https://htn.almazovcentre.ru/jour/article/view/425</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Бронхиальная астма (БА) является серьезной медицинской проблемой. В большинстве стран распространенность БА возрастает. Установлено, что частота обнаружения артериальной гипертензии (АГ) у лиц, страдающих БА, составляет около 30 %. Ухудшение функции легких является столь же сильным предиктором сердечно-сосудистой летальности, как и основные кардиоваскулярные факторы риска.</p><p>Цель исследования — выявление особенностей ремоделирования сердца при разной степени тяжести БА на фоне АГ.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании 2008–2015 гг. участвовал 91 пациент с различной степенью тяжести БА в стадии контролируемости в сочетании с АГ 1–2 степени тяжести, из них 26 пациентов (29 %) с легкой степенью тяжести БА, 34 (37 %) со средней степенью тяжести БА, 31 (34 %) — с тяжелой БА. Все обследованные пациенты были амбулаторными, получали адекватно подобранную базисную терапию БА ингаляционными глюкокортикостероидами. Испытуемые использовали β2‑адреномиметики короткого действия по потребности. Для сравнительного анализа была взята группа пациентов с АГ 1–2 степени (n = 30) и группа лиц с БА различных степеней тяжести в стадии контроля (n = 32). Всем испытуемым проводилась эхокардиоскопия на аппарате «Acuson 128XP/10c» (США).</p></sec><sec><title>Результаты и выводы</title><p>Результаты и выводы. Гипертрофия миокарда левого желудочка и диастолическая дисфункция были выявлены у пациентов всех исследуемых групп, но число их было больше в группе с сочетанной патологией. Доли испытуемых с гипертрофией и диастолической дисфункцией были тем больше, чем выше была тяжесть бронхообструктивного синдрома в группах при неизменной АГ 1–2 степени. Систолическая дисфункция не зарегистрирована ни в одной из групп данного исследования.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Bronchial asthma (BA) is a serious medical problem. The number of patients with the first manifestations at age older than 40–50 years has increased. The frequency of arterial hypertension (HTN) in BA patients was found to be about 30 %.</p></sec><sec><title>Objective</title><p>Objective. To reveal the characteristics of cardiac remodeling at different severity degrees of BA in hypertensive patients.</p></sec><sec><title>Design and methods</title><p>Design and methods. Altogether 91 patients were enrolled in the study in 2008–2015 years, they presented with controlled BA of varying severity associated with 1–2 degree HTN. Of these, 26 patients (29 %) had mild BA, 34 (37 %) — moderate BA severity, 31 (34 %) — severe BA. All examined subjects were outpatients and received adequately chosen basic BA therapy by inhaled corticosteroids. On demand, they used a β2‑agonists of short action. A group of patients with 1–2 degree HTN (n = 30), and a group of patients with different severity of controlled BA (n = 32) served as controls. All patients underwent echocardioscopy (Acuson 128XP/10c, USA).</p></sec><sec><title>Results and conclusions</title><p>Results and conclusions. Left ventricular hypertrophy and diastolic dysfunction were found in all groups, but their number was greater in the group with comorbidities. The number of patients with hypertrophy and diastolic dysfunction was greater with the higher severity of bronchial obstruction in groups with 1–2 degree HTN. Systolic dysfunction was registered in none of the groups.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>бронхиальная астма</kwd><kwd>ремоделирование сердца</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>bronchial asthma</kwd><kwd>heart remodeling</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Барсуков А. В., Казанцев В. А., Таланцева М. С., Николаев А. В., Курганова Т. А. Артериальная гипертензия у пациентов с бронхолегочными заболеваниями. В фокусе проблемы — сердце как орган-мишень. Артериальная гипертензия. 2005;11(3):48–54. [Barsukov AV, Kazantsev VA, Talantseva MS, Nikolaev AV, Kurganova TA. Arterial hypertension in patients with bronchopulmonary diseases. The focus of the problem — the heart as a target organ. Arterial’naya Gipertenziya = Arterial Hypertension. 2005;11(3):48–54. In Russian].</mixed-citation><mixed-citation xml:lang="en">Barsukov AV, Kazantsev VA, Talatseva MS, NikolaevAV, Kurganova TA. Arterial hypertension in patients with bronchopulmonary diseases. The focus of the problem — the heart as a target organ. Arterial’naya Gipertenziya = Arterial Hypertension. 2005;11(3):48–54.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гречишникова О. В. Клиническое течение артериальной гипертензии на фоне бронхиальной астмы в условиях Севера: автореф. дисс. канд. мед. наук. Тюмень, 2010. 23 с. [Grechishnikova OV. The clinical course of hypertension on the background of asthma in the North: PhD thesis. Tyumen, 2010. 23 p. In Russian].</mixed-citation><mixed-citation xml:lang="en">Grechishnikova OV. The clinical course of hypertension on the background of asthma in the North: PhD thesis. Tyumen, 2010. 23 p.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кароли Н. А., Ребров А. П. Коморбидность у больных хронической обструктивной болезнью легких: место кардиоваскулярной патологии. Рациональная фармакотерапия в кардиологии. 2009;4:9–16. [Karoly NA, Rebrov AP. Comorbidity in patients with chronic obstructive pulmonary disease: the place of cardiovascular disease. Ratsionalnaya Farmakoterapiya v Kardiologii = Rational Pharmacotherapy in Cardiology. 2009;4:9– 16. In Russian].</mixed-citation><mixed-citation xml:lang="en">Karoly NA, Rebrov AP. Comorbidity in patients with chronic obstructive pulmonary disease: the place of cardiovascular disease. Ratsionalnaya Farmakoterapiya v Kardiologii = Rational Pharmacotherapy in Cardiology. 2009;4:9–16.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Пахомя Н. С., Урясьев О. М. Структурно-функциональное ремоделирование миокарда у больных бронхиальной астмой с сопутствующей сердечно-сосудистой патологией. Земский врач. 2015;1(25):28–30. [Pakhomya NS, Uryasev OM. Structural and functional myocardial remodeling in asthmatic patients combined with cardiovascular pathology. Zemskij vrach = A Physician. 2015;1(25):28–30. In Russian].</mixed-citation><mixed-citation xml:lang="en">Pakhomya NS, Uryasev OM. Structural and functional myocardial remodeling in asthmatic patients combined with cardiovascular pathology. Zemskij vrach = A Physician. 2015;1(25):28–30.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рябова А. Ю. Особенности ремоделирования сердца у больных бронхиальной астмой и хронической болезнью сердца: автореф. … дисс. д‑ра мед. наук. Санкт- Петербург, 2010. 35 с. [Ryabova AYu. Remodeling of the heart in patients with bronchial asthma and chronic heart disease: Dr. med. thesis. St Petersburg, 2010. 35 p. In Russian].</mixed-citation><mixed-citation xml:lang="en">Ryabova AYu. Remodeling of the heart in patients with bronchial asthma and chronic heart disease: Dr. med. thesis. St Petersburg, 2010. 35 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Фроленкова Л. А. Коронарный риск и особенности течения ишемической болезни сердца на фоне бронхиальной астмы в условиях Севера: автореф. … дисс. канд. мед. наук. Томск, 2009. 30 с. [Frolenkova LA. Coronary risk and peculiarities of coronary heart disease on the background of asthma in the North: PhD thesis. Tomsk, 2009. 30 p. In Russian].</mixed-citation><mixed-citation xml:lang="en">Frolenkova LA. Coronary risk and peculiarities of coronary heart disease on the background of asthma in the North: PhD thesis. Tomsk, 2009. 30 p.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Чучалин А. Г., Цой А. Н., Архипов В. В., Гавришина Е. А. Бронхиальная астма в России: результаты национального исследования качества медицинской помощи больным бронхиальной астмой. Пульмонология. 2014;2:11. [Chuchalin AG, Tsoi AN, Arkhipov VV, Gavrishina EA. Bronchial asthma in Russia: results of a national study of the care quality in patients with bronchial asthma. Pulmonology. 2014;2:11. In Russian].</mixed-citation><mixed-citation xml:lang="en">Chuchalin AG, Tsoi AN, ArkhipovVV, Gavrishina EA. Bronchial asthma in Russia: results of a national study of the care quality in patients with bronchial asthma. Pulmonology. 2014;2:11.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Шаповалова Т. Г., Шелобанова Н. В., Волкова М. В., Рябова А. Ю., Лекарева Л. И. Особенности ремоделирования сердца у больных хронической обструктивной болезнью легких, сочетанной с ишемической болезнью сердца. Саратовский научно- медицинский журнал. 2009;5(4):352–355. [Shapovalova TG, Shelobanova NV, Volkova MV, Ryabova AYu, Lekareva LI. Features of cardiac remodeling in patients with chronic obstructive pulmonary disease combined with coronary heart disease. Saratovskij Nauchno- meditsinskij Zhurnal = Saratov Journal of Medical Science. 2009;5(4):352–355. In Russian].</mixed-citation><mixed-citation xml:lang="en">Shapovalova TG, Shelobanova NV, Volkova MV, Ryabova AYu, Lekareva LI. Features of cardiac remodeling in patients with chronic obstructive pulmonary disease combined with coronary heart disease. Saratovskij Nauchnomeditsinskij Zhurnal = Saratov Journal of Medical Science. 2009;5(4):352–355.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bakakos P, Patentalakis G, Papi A. Vascular biomarkers in asthma and COPD. Curr Top Med Chem. 2016;16(14):1599–1609.</mixed-citation><mixed-citation xml:lang="en">Bakakos P, Patentalakis G, Papi A. Vascular biomarkers in asthma and COPD. Curr Top Med Chem. 2016;16(14):1599–1609.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Olivieri D, Chetta A. Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease. Chem Immunol Allergy. 2014;99:216–225. doi: 10. 1159/000353307</mixed-citation><mixed-citation xml:lang="en">Olivieri D, Chetta A. Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease. Chem Immunol Allergy. 2014;99:216–25. doi: 10.1159/000353307.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease and bronchial asthma. J Am Soc Echocardiogr. 2002;15(6):633–639.</mixed-citation><mixed-citation xml:lang="en">Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease and bronchial asthma. J Am Soc Echocardiogr. 2002;15(6):633–9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Сherniaev A, Samsonova A, Avdeev S. Pulmonary vascular remodeling in COPD versus bronchial asthma. Eur Respir J. 2009;22(Suppl. 45):82.</mixed-citation><mixed-citation xml:lang="en">Сherniaev A, Samsonova A, Avdeev S. Pulmonary vascular remodeling in COPD versus bronchial asthma. Eur Respir J. 2009;22(Suppl. 45):82.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cunha DM, Cunha AB, Martins UA, Pinheiro LA, Romêo LJ, de Moraes AV et al. Echocardiographic assessment of the different left ventricular geometric patterns in hypertensive patents. Arq Bras Cardiol. 2001;76(1):15–28.</mixed-citation><mixed-citation xml:lang="en">Cunha DM, Cunha AB, Martins UA, Pinheiro LA, Romêo LJ, de Moraes AV et al. Echocardiographic assessment of the different left ventricular geometric patterns in hypertensive patents. Arq Bras Cardiol. 2001;76 (1):15–28.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chronic respiratory diseases: Burden [Computer file]. 2007. URL: http://www. who.com/Chronic respiratory diseases. GINA 2014. www.ginasthma.org</mixed-citation><mixed-citation xml:lang="en">Chronic respiratory diseases: Burden [Computer file]. 2007. URL: http://www.who.com/Chronic respiratory diseases. GINA 2014. www.ginasthma.org</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Harkness LM, Kanabar V, Sharma HS, Westergren-Thorsson G, Larsson-Callerfelt AK. Pulmonary vascular changes in asthma and COPD. Pulm Pharmacol Ther. 2014;29(2):144– 155. doi: 10.1016/j.pupt.2014.09.003.</mixed-citation><mixed-citation xml:lang="en">Harkness LM, Kanabar V, Sharma HS, WestergrenThorsson G, Larsson-Callerfelt AK. Pulmonary vascular changes in asthma and COPD. Pulm Pharmacol Ther. 2014;29(2):144–55. doi: 10.1016/j.pupt.2014.09.003.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Keglowich LF, Borger P. The three A’s in asthma — airway smooth muscle, airway remodeling and angiogenesis. Open Respir Med J. 2015;9:70–80. doi: 10.2174/1874306401509010070.</mixed-citation><mixed-citation xml:lang="en">Keglowich LF, Borger P. The three A’s in asthma — airway smooth muscle, airway remodeling and angiogenesis. Open Respir Med J. 2015;9:70–80. doi: 10.2174/1874306401509010070.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JD, Lee A, Choi J, Park Y, Kang H, Chang W et al. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med. 2015;47:e175. doi:10. 1038/emm.2015.45.</mixed-citation><mixed-citation xml:lang="en">Kim JD, Lee A, Choi J, Park Y, Kang H, Chang W et al. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med. 2015;47: e175. doi: 10.1038/emm.2015.45.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. COPD 2012;9(2):131–141.</mixed-citation><mixed-citation xml:lang="en">Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. COPD 2012;9(2):131–41.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vaidya B, Gupta V. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to sitespecific drug delivery. J Control Release. 2015;211:118–33. doi:10. 1016/j.jconrel.2015.05.287</mixed-citation><mixed-citation xml:lang="en">Vaidya B, Gupta V. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery. J Control Release. 2015;211:118–33. doi: 10.1016/j.jconrel.2015.05.287.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">White WB, Cook GE, Kowey PR, Calverley PM, Bredenbröker D, Goehring UM et al. Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. Chest. 2013;144(3):758–765.</mixed-citation><mixed-citation xml:lang="en">White WB, Cook GE, Kowey PR, Calverley PM, Bredenbröker D, Goehring UM et al. Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. Chest. 2013;144(3):758–765.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
